Table 1. Patient overview and initial features.
Characteristic | Rosuvastatin group | Atorvastatin group | |
Age (years) | Mean ± SD | 62.4 ± 8.3 | 63.1 ± 7.9 |
Age group categories n (%) | < 65 years | 118 (59.00%) | 116 (58.00%) |
≥ 65 years | 82 (41.00%) | 84 (42.00%) | |
Gender categories n (%) | Male | 151 (75.50%) | 154 (77.00%) |
Female | 49 (24.50%) | 46 (23.00%) | |
Comorbidities n (%) | Hypertension | 116 (58.00%) | 109 (54.50%) |
Diabetes mellitus | 83 (41.50%) | 92 (46.00%) | |
Smoking | 42 (21.00%) | 36 (18.00%) | |
History of dyslipidemia | 93 (46.50%) | 98 (49.00%) | |
Previous myocardial infarction | 54 (27.00%) | 48 (24.00%) | |
Previous PCI | 27 (13.50%) | 33 (16.50%) | |
Previous CABG | 16 (8.00%) | 21 (10.50%) |